DD, not so bad a geuss.
After all they are in the B-I network and they offer a brand new facility.
Then again, one would think that in the production of Biologics the B-I model becomes some less flexible given the need for FDA approval for each line and the need of a root molecule.
So shifting manufacturing around as in the 'bakery' approach where all know and are equipped to make bread, will be more difficult with biologics.
Maybe AVID I will do the bakery-grade productions and all biologics are made in Avid II as of now.
Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.